Mar 4, 2026 08:42AM
Mar 4, 2026 06:42AM
Mar 3, 2026 09:37AM
Mar 2, 2026 06:00AM
Jan 29, 2026 08:00AM
Jan 27, 2026 08:04AM
Jan 27, 2026 08:00AM Belite Bio Completes Enrollment in the DRAGON II Clinical Trial of Tinlarebant for Stargardt Disease (STGD1)
Jan 26, 2026 06:12AM
Dec 3, 2025 08:44AM
Dec 1, 2025 06:00AM
Dec 1, 2025 06:00AM
Nov 10, 2025 08:00AM
Sep 15, 2025 07:28AM
Sep 10, 2025 08:51AM Benchmark Reiterates Buy Rating on Belite Bio, Inc, ADR (BLTE) Following PIPE Transaction
Aug 12, 2025 09:42AM
Aug 11, 2025 06:00AM
Jul 2, 2025 03:00AM
May 22, 2025 08:39AM
May 21, 2025 03:00AM
May 15, 2025 09:10AM
May 15, 2025 07:23AM Cantor Fitzgerald Reiterates Overweight Rating on Belite Bio, Inc, ADR (BLTE)
May 13, 2025 09:00PM
Apr 29, 2025 08:00AM
Mar 17, 2025 06:00AM
Nov 27, 2024 03:00AM
Nov 12, 2024 01:00AM
Oct 14, 2024 08:00AM
Sep 10, 2024 08:00AM Belite Bio Announces First Patient Dosed in Phase 2/3 DRAGON II Trial of Tinlarebant for the Treatment of Stargardt Disease
Aug 9, 2024 04:30PM
Jun 27, 2024 08:49AM
Jun 12, 2024 02:55AM
May 13, 2024 09:50PM
May 6, 2024 08:00AM
May 1, 2024 04:15PM
Mar 22, 2024 08:00AM Belite Bio (BLTE) Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japan
Mar 22, 2024 08:00AM
Mar 11, 2024 09:27PM
Nov 13, 2023 08:15PM
Nov 6, 2023 04:00PM
Nov 6, 2023 08:00AM
Oct 27, 2023 08:00AM
Aug 8, 2023 10:17PM Belite Bio Reports Second Quarter 2023 Operational Highlights and Financial Results
Jul 27, 2023 05:00PM
Jul 24, 2023 06:04AM
May 10, 2023 07:58PM
Apr 25, 2023 04:30PM
Apr 25, 2023 04:30PM
Apr 25, 2023 04:30PM
Apr 3, 2023 05:37AM Belite Bio (BLTE) Reports FY22, Provides Operational Highlights
Mar 31, 2023 07:03PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All